Treatment of recurrent hepatitis C in liver transplant recipients: Is there any histologic benefit?

Liver Transplantation

Volumn 9, Issue 4, 2003, Pages 354-359

  Nair, Satheesh ^a   Khan, Saad ^a   Loss, George ^a   Eason, James ^a   Blazek, Jamie ^a   Lipscomb, Jeanie ^a   Mason, Andrew ^a  

^a OCHSNER CLINIC FOUNDATION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA2B INTERFERON; ANTIDEPRESSANT AGENT; ANTIVIRUS AGENT; HEMOPOIETIC GROWTH FACTOR; INTERFERON; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; RECOMBINANT ERYTHROPOIETIN; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR; RECOMBINANT INTERLEUKIN 11; RIBAVIRIN; TACROLIMUS;

ADULT; ANEMIA; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOPENIA; DISEASE COURSE; DOSE RESPONSE; DRUG DOSE REDUCTION; DRUG WITHDRAWAL; FEMALE; HEPATITIS C; HUMAN; INFLAMMATION; LIVER BIOPSY; LIVER FIBROSIS; LIVER GRAFT; LIVER HISTOLOGY; LIVER TRANSPLANTATION; MALE; NEUTROPENIA; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; RECIPIENT; RECURRENT VIRUS INFECTION; SCORING SYSTEM; THROMBOCYTOPENIA; VIROLOGY;

EID: 0037389356     PISSN: 15276465     EISSN: None     Source Type: Journal    
DOI: 10.1053/jlts.2003.50068     Document Type: Article

References (22)

1. Detre K, Belle S, Lombardeo M. Liver transplantation for chronic hepatitis C. Viral Hepatol Rev 1996;2:219-228.
2. Charlton M, Seaberg E, Wiesner R, Everhart J, Zetterman R, Lake J, et al. Predictors of patients and graft survival following liver transplantation for hepatitis C. Hepatology 1998;28:823-830.
3. Konig V, Bauditz J, Lobeck H, Lusebrink R, Neuhaus P, Blumhardt G, et al. Hepatitis C virus reinfection in allografts after orthotopic liver transplantation. Hepatology 1992;16:1137-1143.
4. Feray C, Samuel D, Thiers V, Gigou M, Pichon F, Bismuth A, et al. Reinfection of liver graft by hepatitis C virus after liver transplantation. J Clin Invest 1992;89:1361-1365.
5. Weinstein JS, Poterucha JJ, Zein N, Wiesner RH, Persing DH, Rakela J. Epidemiology and natural history of hepatitis C infections in liver transplant recipients. J Hepatol 1995;22:154-159.
6. Gane EJ, Portmann BC, Naoumov NV, Smith HM, Underhill JA, Donaldson PT, et al. Persistent hepatitis C virus infection after liver transplant. N Engl J Med 1996;334:815-820.
7. Wright TL, Donegan E, Hsu HH, Ferrell L, Lake JR, Kim M, et al. Recurrent and acquired hepatitis C viral hepatitis in liver transplant recipients. Gastroenterology 1992;103:317-322.
8. Gretch DR, Bacchi CE, Corey L, dela Rosa C, Lesniewski RR, Kowdley K, et al. Persistent hepatitis C virus infection after liver transplantation. Clinical and virological features. Hepatology 1995;22:1-9.
9. Di Bisceglie AM. Liver transplantation of hepatitis C: The promise and the challenge [editorial]. Hepatology 1995;22:660-662.
10. Feray C, Caccamo L, Alexander GJ, Ducot B, Gugenheim J, Casanovas T, et al. European collaborative study on factors influencing outcome after liver transplantation for hepatitis C. European Concerted Action on Viral Hepatitis (EUROHEP) Group. Gastroenterology 1999;117:619-625.
11. Cattral MS, Krajden M, Wanless IR, Rezig M, Cameron R, Greig PD, et al. A pilot study of ribavirin therapy for recurrent hepatitis C virus infection after liver transplantation. Transplantation 1996;61:1483-488.
12. Wright TL, Combs C, Kim M, Ferrell L, Bacchetti P, Ascher N, et al. Interferon-alpha therapy for hepatitis C virus infection after liver transplantation. Hepatology 1994;20:773-779.
13. Singh N, Gayowsli T, Wannstedt CF, Marino IR, Wagener MM. Interferon-alpha therapy for hepatitis C virus recurrence after liver transplantation: Long-term response with maintenance therapy. Clin Transplant 1996;10:348-351.
14. Colter SJ, Ganger DR, Kaur S, et al. Daily interferon therapy for treatment of hepatitis C infection in liver transplant recipients. Hepatology 1999;30:246A.
15. Bizollon T, Palazzo U, Ducerf C, Chevallier M, Elliott M, Baulieux J, et al. Pilot study of the combination of interferon alfa and ribavirin as therapy of recurrent hepatitis C after liver transplantation. Hepatology 1997;26:500-504.
16. El-Amin OA, Poterrucha JJ, Zein NN, et al. Interferon/ribavirin therapy for recurrent hepatitis C after liver transplantation. Hepatology 1999;30:247A.
17. Fischer L, Sterneck M, Valentin-Gamazo C, Feucht HH, Malago M, Broelsch CE. Treatment of severe recurrent hepatitis C after liver transplantation with ribavirin plus interferon alpha. Transpl Proc 1999;31:494-495.
18. Shakil AO, McGuire B, Crippin J, Teperman L, Demetris AJ, Conjeevaram H, et al. A pilot study of interferon alfa and ribavirin combination in liver transplant recipients with recurrent hepatitis C. Hepatology 2002;36:1253-1258
19. Desmet VJ, Gerber M, Hoofnagle JH, Manns M, Scheuer PJ. Classification of chronic hepatitis: Diagnosis, grading and staging. Hepatology 1994;19:1513-1520.
20. Berenguer M, Lopez-Labrador FX, Wright TL. Hepatitis C and liver transplantation. J Hepatol 2001;35:666-678.
21. Narayanan Menon KV, Poterucha JJ, El-Amin OM, Burgart LJ, Kremers WK, Rosen CB, et al. Treatment of posttransplantation recurrence of hepatitis C with interferon and ribavirin: Lessons on tolerability and efficacy. Liver Transpl 2002; 8:623-629.
22. Pelletier SJ, Raymond DP, Crabtree TD, Berg CL, Iezzoni JC, Hahn YS, et al. Hepatitis C-induced hepatic allograft injury is associated with a pretransplantation elevated viral replication rate. Hepatology 2000;32:418-426.